Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 3519087)

Published in Crit Rev Toxicol on January 01, 1986

Authors

R Kato

Articles citing this

Mouse models for the study of colon carcinogenesis. Carcinogenesis (2008) 2.10

Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol (2011) 1.38

DNA adduct formation of 4-aminobiphenyl and heterocyclic aromatic amines in human hepatocytes. Chem Res Toxicol (2011) 0.98

Reactions of oxidatively activated arylamines with thiols: reaction mechanisms and biologic implications. An overview. Environ Health Perspect (1994) 0.94

N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes. Environ Health Perspect (1994) 0.87

Using biomarkers of genetic susceptibility to enhance the study of cancer etiology. Environ Health Perspect (1995) 0.86

UDP-glucuronosyltransferase-mediated metabolic activation of the tobacco carcinogen 2-amino-9H-pyrido[2,3-b]indole. J Biol Chem (2012) 0.85

Mass Spectrometric Characterization of Human Serum Albumin Adducts Formed with N-Oxidized Metabolites of 2-Amino-1-methylphenylimidazo[4,5-b]pyridine in Human Plasma and Hepatocytes. Chem Res Toxicol (2015) 0.79

Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice. Chem Res Toxicol (2011) 0.78

Mouse models of colorectal cancer. Chin J Cancer (2011) 0.78

Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring. Environ Health Perspect (1993) 0.77

Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring. Environ Health Perspect (1994) 0.75

N-Acetyltransferase polymorphism and human cancer risk. Environ Health Prev Med (2000) 0.75

Mutagenicity testing of 9-N-substituted adenines and their N-oxidation products. Environ Health Perspect (1993) 0.75

Dietary modulation of DNA adduct formation of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in the male Fischer 344 rat. Environ Health Perspect (1994) 0.75

Articles by these authors

(truncated to the top 100)

Spred is a Sprouty-related suppressor of Ras signalling. Nature (2001) 2.87

Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29

L-arginine-induced hypotension. Lancet (1990) 1.77

JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65

Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase. Carcinogenesis (1990) 1.49

Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J Biochem (2000) 1.48

Crystal structure of a repair enzyme of oxidatively damaged DNA, MutM (Fpg), from an extreme thermophile, Thermus thermophilus HB8. EMBO J (2000) 1.48

L-arginine-induced hypotension. Lancet (1991) 1.47

Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol (1990) 1.47

Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem (2001) 1.44

Crystal structure of Thermus thermophilus HB8 UvrB protein, a key enzyme of nucleotide excision repair. J Biochem (1999) 1.43

Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis. J Biol Chem (1994) 1.43

The origin of hypsarrhythmia and tonic spasms in West syndrome: evidence from a case of porencephaly and hydrocephalus with focal hypsarrhythmia. Brain Dev (1999) 1.40

Guidance with real-time CT fluoroscopy: early clinical experience. Radiology (1996) 1.40

Sex-related differences in drug metabolism. Drug Metab Rev (1974) 1.38

cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem Biophys Res Commun (1990) 1.37

Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.37

Studies on the mechanism of drug-induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-[14C]-phenylalanine incorporation. Mol Pharmacol (1966) 1.36

Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics (1977) 1.35

Comparative genomic sequencing identifies novel tissue-specific enhancers and sequence elements for methylation-sensitive factors implicated in Igf2/H19 imprinting. Genome Res (2000) 1.30

Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 1.26

Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol (1968) 1.23

Active site of mu-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J Biol Chem (1991) 1.21

Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol (1986) 1.20

Limit on neutrinoless ββ decay of 136Xe from the first phase of KamLAND-Zen and comparison with the positive claim in 76Ge. Phys Rev Lett (2013) 1.18

Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett (1995) 1.17

Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant (2011) 1.17

Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes. Mol Pharmacol (1968) 1.16

Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy (2012) 1.16

Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci (1993) 1.16

Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J Biol Chem (1987) 1.15

Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med (1994) 1.13

Failure of 1-oleoyl-2-acetylglycerol to mimic the cell-differentiating action of 12-O-tetradecanoylphorbol 13-acetate in HL-60 cells. J Biol Chem (1985) 1.10

Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J (1992) 1.10

Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem (1994) 1.10

A methylation imprint mark in the mouse imprinted gene Grf1/Cdc25Mm locus shares a common feature with the U2afbp-rs gene: an association with a short tandem repeat and a hypermethylated region. Genomics (1998) 1.10

Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci (1995) 1.09

Gene conversion and differential regulation in the rat P-450 IIA gene subfamily. Purification, catalytic activity, cDNA and deduced amino acid sequence, and regulation of an adult male-specific hepatic testosterone 15 alpha-hydroxylase. J Biol Chem (1988) 1.09

Dopamine receptor blocking activity of sulpiride in the central nervous system. Jpn J Pharmacol (1977) 1.07

A 1.2-megabase BAC/PAC contig spanning the 14q13 breakpoint of t(2; 14) in a mirror-image polydactyly patient. Genomics (1997) 1.06

Mismatch DNA recognition protein from an extremely thermophilic bacterium, Thermus thermophilus HB8. Nucleic Acids Res (1996) 1.05

Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. J Vet Intern Med (2008) 1.05

Physical interactions between DinI and RecA nucleoprotein filament for the regulation of SOS mutagenesis. EMBO J (2001) 1.04

The novel substrate recognition mechanism utilized by aspartate aminotransferase of the extreme thermophile Thermus thermophilus HB8. J Biol Chem (1998) 1.04

Effect of phenobarbital on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different age. J Biochem (1968) 1.02

Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of old rats. Jpn J Pharmacol (1968) 1.02

Novel Pauli-paramagnetic quantum phase in a Mott insulator. Nat Commun (2012) 1.02

Epithelial myoepithelial tumour of the tracheal gland. J Clin Pathol (1993) 1.02

Structure of Thermus thermophilus HB8 aspartate aminotransferase and its complex with maleate. Biochemistry (1999) 1.01

Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes. J Pharmacol Exp Ther (1965) 1.01

Stimulation by ATP of inositol trisphosphate accumulation and calcium mobilization in cultured adrenal chromaffin cells. J Neurochem (1989) 1.01

Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine. J Med Chem (1999) 0.99

An aspartate aminotransferase from an extremely thermophilic bacterium, Thermus thermophilus HB8. J Biochem (1996) 0.99

Domain organization and functional analysis of Thermus thermophilus MutS protein. Nucleic Acids Res (1998) 0.99

Neurotransmitter release from synaptotagmin-deficient clonal variants of PC12 cells. Science (1992) 0.98

Development of tolerance to alpha-2 adrenergic agonists in the vascular system of the rat after chronic treatment with clonidine. J Pharmacol Exp Ther (1984) 0.97

Surgical treatment of advanced thyroid carcinoma invading the trachea. J Thorac Cardiovasc Surg (1991) 0.97

Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.97

Evidence for early aging in the mucosal immune system. J Immunol (2000) 0.97

Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses. J Immunol (2001) 0.97

Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta (1996) 0.96

Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy. Brain Dev (2000) 0.96

Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum. J Pharmacol Exp Ther (1982) 0.96

Inhibition of drug-metabolizing enzymes of liver microsomes by hydrazine derivatives in relation to their lipid solubility. Jpn J Pharmacol (1969) 0.96

Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19. Biochem Pharmacol (1999) 0.95

Characteristics and differences in the hepatic mixed function oxidases of different species. Pharmacol Ther (1979) 0.95

Sex difference of cytochrome P-450 in the rat: purification, characterization, and quantitation of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. Arch Biochem Biophys (1983) 0.95

Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation. J Pharmacol Exp Ther (1981) 0.94

Mott transition in a valence-bond solid insulator with a triangular lattice. Phys Rev Lett (2007) 0.94

Increases in NO2-/NO3- excretion in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure. Clin Sci (Lond) (1992) 0.94

Role of mucosal antibodies in viral infections. Curr Top Microbiol Immunol (2001) 0.94

Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. J Dermatol Sci (1994) 0.94

Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Mol Pharmacol (1989) 0.94

Impairment of mycophenolate mofetil absorption by iron ion. Clin Pharmacol Ther (2000) 0.94

Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulfotransferase. Biochem Biophys Res Commun (1989) 0.94

Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res (1983) 0.93

In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells. Blood (1998) 0.93

The RadA protein from a hyperthermophilic archaeon Pyrobaculum islandicum is a DNA-dependent ATPase that exhibits two disparate catalytic modes, with a transition temperature at 75 degrees C. Eur J Biochem (2000) 0.93

Drug metabolism under pathological and abnormal physiological states in animals and man. Xenobiotica (1977) 0.92

Glutathione conjugation of arylnitroso compound: detection and monitoring labile intermediates in situ inside a fast atom bombardment mass spectrometer. Biochem Biophys Res Commun (1984) 0.92

Nucleotide sequence of a full-length cDNA (PST-1) for aryl sulfotransferase from rat liver. Nucleic Acids Res (1990) 0.92

Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome. Bone Marrow Transplant (2011) 0.92

Cytochrome b5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proc Natl Acad Sci U S A (1990) 0.92

Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol (1986) 0.92

Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol (1990) 0.91

Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin Invest (1994) 0.91

Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact (1998) 0.91

Del(12)(p11.21p12.2) associated with an asphyxiating thoracic dystrophy or chondroectodermal dysplasia-like syndrome. Am J Med Genet (1995) 0.91

Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis. Oncogene (2009) 0.91

Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD. Bone Marrow Transplant (2012) 0.91

Cell therapy for facial anti-aging. Med J Malaysia (2008) 0.90

Cytochrome P450 in livers of diabetic rats: regulation by growth hormone and insulin. Arch Biochem Biophys (1989) 0.90

Induction of alkaline phosphatase by cyclic AMP or its dibutyryl derivative in a hybrid line between mouse and Chinese hamster in culture. Biochem Biophys Res Commun (1972) 0.90

Molecular mapping of a translocation breakpoint at 14q13 in a patient with mirror-image polydactyly of hands and feet. Hum Genet (1997) 0.90

Functional shift from muscarinic to nicotinic cholinergic receptors involved in inositol trisphosphate and cyclic GMP accumulation during the primary culture of adrenal chromaffin cells. Biochem J (1988) 0.90

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet (2005) 0.90

N-hydroxylation of carcinogenic and mutagenic aromatic amines. Environ Health Perspect (1983) 0.90

Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension (1995) 0.90

Adrenergic regulation of blood glucose levels: possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release. J Pharmacol Exp Ther (1980) 0.90